Kestra Medical Technologies, Ltd.
As of Oct 22, 2026, Kestra Medical Technologies is in Stage 2, the uptrend phase, now in week 10 (since Aug 14, 2026). It closed at $28.32, 3.6% below its 52-week high and above its 200-day average, which is rising.
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 18 in Medical Instruments & Supplies · #1 of 272 in Health Care
Is KMTS early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
KMTS among Medical Instruments & Supplies21st of 51 by relative strength
All 51 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | PLSE | Stage 2 · wk 34 | 98 | +1.3% |
| 2 | PDEX | Stage 2 · wk 36 | 97 | −13.3% |
| 3 | HBIO | Stage 2 · wk 11 | 95 | +3.6% |
| 4 | ATRC | Stage 2 · wk 10 | 89 | −1.1% |
| 5 | WST | Stage 2 · wk 24 | 82 | +4.8% |
| 6 | BDX | Stage 2 · wk 11 | 81 | +9.8% |
| 7 | ICUI | Stage 3 · wk 1 | 81 | +3.1% |
| 8 | OSUR | Stage 3 · wk 8 | 75 | −4.8% |
| …21 | KMTS | Stage 2 · wk 10 | 60 | +11.0% |
Kestra Medical Technologies: quick answers
What stage is Kestra Medical Technologies in?
As of Oct 22, 2026, Kestra Medical Technologies (KMTS) is in Stage 2, the uptrend phase. It entered Stage 2 on Aug 14, 2026 and is in week 10. What the four stages mean
Is Kestra Medical Technologies in an uptrend?
Yes. Kestra Medical Technologies is in a Stage 2 uptrend. It trades 19.7% above its 200-day average, which is rising.
How far is Kestra Medical Technologies from its 52-week high?
Kestra Medical Technologies closed at $28.32 on Oct 22, 2026, 3.6% below its 52-week high of $29.37. Its 52-week low is $17.87.
How has Kestra Medical Technologies performed over the past year?
As of Oct 22, 2026, Kestra Medical Technologies is up 7.3% over the past year and up 16.1% so far in 2026.
Which sector and industry is Kestra Medical Technologies in?
Kestra Medical Technologies is in the Medical Instruments & Supplies industry, part of the Health Care sector.
About this companyHealth Care· Medical Instruments & Supplies
Kestra Medical Technologies, Ltd. operates as a wearable medical device and digital healthcare company. It focuses on transforming patient outcomes in cardiovascular disease through connected monitoring, therapeutic intervention, and data-driven clinical insights. The company also develops and commercializes Cardiac Recovery System platform, an integrated cardiac recovery ecosystem designed to support patients at elevated risk of sudden cardiac arrest (SCA) during vulnerable periods of recovery. Its platform provides ASSURE Wearable Cardioverter Defibrillator (WCD), which continuously monitors patient heart rhythms and automatically delivers defibrillation therapy when life-threatening ventricular arrhythmias are detected; digital patient engagement and clinical workflow solutions designed to improve patient adherence, support care coordination, and provide actionable clinical insights throughout the recovery process; and integrated platform generates continuous cardiac rhythm data and clinically actionable insights. Kestra Medical Technologies, Ltd. was founded in 2014 and is based in Kirkland, Washington.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.